Milestone Scientific (NYSE:MLSS) Coverage Initiated at StockNews.com

StockNews.com started coverage on shares of Milestone Scientific (NYSE:MLSS) in a research report sent to investors on Thursday. The brokerage issued a hold rating on the stock.

Separately, Benchmark started coverage on shares of Milestone Scientific in a research report on Thursday, October 10th. They issued a “speculative buy” rating and a $1.25 price target on the stock.

Milestone Scientific Price Performance

MLSS opened at $0.86 on Thursday. The stock’s 50 day simple moving average is $0.95 and its 200 day simple moving average is $0.81. The stock has a market cap of $66.18 million, a P/E ratio of -8.57 and a beta of 1.08. Milestone Scientific has a 1-year low of $0.52 and a 1-year high of $1.10.

Milestone Scientific (NYSE:MLSS) last released its quarterly earnings results on Thursday, August 15th. The company reported ($0.02) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.01) by ($0.01). Milestone Scientific had a negative return on equity of 60.78% and a negative net margin of 54.87%. The firm had revenue of $1.85 million for the quarter.

Insider Buying and Selling

In other news, Director Leonard Osser sold 141,913 shares of Milestone Scientific stock in a transaction dated Wednesday, August 21st. The shares were sold at an average price of $0.95, for a total transaction of $134,817.35. Following the completion of the sale, the director now directly owns 4,602,506 shares in the company, valued at $4,372,380.70. The trade was a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through the SEC website. In the last quarter, insiders sold 143,122 shares of company stock worth $136,026. 24.75% of the stock is owned by corporate insiders.

About Milestone Scientific

Milestone Scientific Inc, a biomedical technology research and development company, patents, designs, develops, and commercializes diagnostic and therapeutic injection technologies, and devices for medical, dental, and cosmetic use in the United States, China, and internationally. The company operates through Dental and Medical segments.